Movement Alert｜Joinn Laboratories Rises 6.62% in Regular Trading, Barclays Increases Stake to 6.12% as CXO Sector Rebounds

Market Focus07-21

On July 21, Joinn Laboratories (06127.HK) rose 6.62% in regular trading, reaching HK$24.92 per share, with turnover of HK$211 million.

The rally was driven by the disclosure that Barclays PLC acquired approximately 3.28 million shares of Joinn Laboratories on July 15 at an average price of HK$24.25 per share, totaling approximately HK$79.54 million. Following the purchase, Barclays' total holding rose to roughly 7.29 million shares, representing a 6.12% stake in the company. Additionally, the broader CXO sector extended its rebound, with peers including WuXi Biologics and WuXi AppTec posting gains on the same day, providing sector-wide support.

The institutional endorsement comes amid elevated market attention on Joinn Laboratories following its H1 earnings guidance forecasting net profit growth of 885% to 1,377%, primarily driven by fair value appreciation of biological assets as experimental primate prices surpassed RMB 200,000 per animal. The company's core laboratory services revenue, however, recorded only modest growth amid ongoing competitive pressures.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1159759211?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-21 13:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159759211","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Joinn Laboratories Rises 6.62% in Regular Trading, Barclays Increases Stake to 6.12% as CXO Sector Rebounds","media":"Market Focus","content":"<p><p>On July 21, Joinn Laboratories (06127.HK) rose 6.62% in regular trading, reaching HK$24.92 per share, with turnover of HK$211 million.</p><p>The rally was driven by the disclosure that Barclays PLC acquired approximately 3.28 million shares of Joinn Laboratories on July 15 at an average price of HK$24.25 per share, totaling approximately HK$79.54 million. Following the purchase, Barclays' total holding rose to roughly 7.29 million shares, representing a 6.12% stake in the company. Additionally, the broader CXO sector extended its rebound, with peers including WuXi Biologics and WuXi AppTec posting gains on the same day, providing sector-wide support.</p><p>The institutional endorsement comes amid elevated market attention on Joinn Laboratories following its H1 earnings guidance forecasting net profit growth of 885% to 1,377%, primarily driven by fair value appreciation of biological assets as experimental primate prices surpassed RMB 200,000 per animal. The company's core laboratory services revenue, however, recorded only modest growth amid ongoing competitive pressures.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Joinn Laboratories Rises 6.62% in Regular Trading, Barclays Increases Stake to 6.12% as CXO Sector Rebounds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Joinn Laboratories Rises 6.62% in Regular Trading, Barclays Increases Stake to 6.12% as CXO Sector Rebounds\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-21 13:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 21, Joinn Laboratories (06127.HK) rose 6.62% in regular trading, reaching HK$24.92 per share, with turnover of HK$211 million.</p><p>The rally was driven by the disclosure that Barclays PLC acquired approximately 3.28 million shares of Joinn Laboratories on July 15 at an average price of HK$24.25 per share, totaling approximately HK$79.54 million. Following the purchase, Barclays' total holding rose to roughly 7.29 million shares, representing a 6.12% stake in the company. Additionally, the broader CXO sector extended its rebound, with peers including WuXi Biologics and WuXi AppTec posting gains on the same day, providing sector-wide support.</p><p>The institutional endorsement comes amid elevated market attention on Joinn Laboratories following its H1 earnings guidance forecasting net profit growth of 885% to 1,377%, primarily driven by fair value appreciation of biological assets as experimental primate prices surpassed RMB 200,000 per animal. The company's core laboratory services revenue, however, recorded only modest growth amid ongoing competitive pressures.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06127","symbol_name":"昭衍新药","start_time":0,"source_url":"","article_id":"1159759211","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159759211","pubTimestamp":1784611124,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 21, Joinn Laboratories (06127.HK) rose 6.62% in regular trading, reaching HK$24.92 per share, with turnover of HK$211 million.The rally was driven by the disclosure that Barclays PLC acquired...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06127":"昭衍新药"},"translate_title":"走势警报|Joinn Laboratories 常规交易中上涨 6.62%，随着 CXO 板块反弹，巴克莱将持股比例增至 6.12%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06127":1},"content_text":"On July 21, Joinn Laboratories (06127.HK) rose 6.62% in regular trading, reaching HK$24.92 per share, with turnover of HK$211 million.The rally was driven by the disclosure that Barclays PLC acquired approximately 3.28 million shares of Joinn Laboratories on July 15 at an average price of HK$24.25 per share, totaling approximately HK$79.54 million. Following the purchase, Barclays' total holding rose to roughly 7.29 million shares, representing a 6.12% stake in the company. Additionally, the broader CXO sector extended its rebound, with peers including WuXi Biologics and WuXi AppTec posting gains on the same day, providing sector-wide support.The institutional endorsement comes amid elevated market attention on Joinn Laboratories following its H1 earnings guidance forecasting net profit growth of 885% to 1,377%, primarily driven by fair value appreciation of biological assets as experimental primate prices surpassed RMB 200,000 per animal. The company's core laboratory services revenue, however, recorded only modest growth amid ongoing competitive pressures.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1159759211","isCrawlerRequest":true}